Live feed08:59:01·1168dSECFilingvia QuantisnowAeglea BioTherapeutics Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Leadership Update, Other Events, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.AGLE· Aeglea BioTherapeutics Inc.Health CareOriginal source
